Paritosh Suman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paritosh Suman has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
David J. Winchester
Department of Surgery, NorthShore University Health System, Evanston, IL
8 shared publicationsRichard A. Prinz
Department of Surgery, NorthShore University Health System, Evanston, IL
8 shared publicationsChi-Hsiung Wang
From: Northshore University HealthSystem, 2650 Ridge Ave, Evanston, IL 60201
5 shared publicationsTricia A. Moo-Young
From: Northshore University HealthSystem, 2650 Ridge Ave, Evanston, IL 60201
5 shared publicationsAnusak Yiengpruksawan
Ganepola AP Ganepola, John R Rutledge, Paritosh Suman, David H Chang, Center for Cancer Research and Genomic Medicine, The Valley Hospital, Paramus, NJ 07652, United States
4 shared publicationsJohn Rutledge
The Daniel and Gloria Blumenthal Cancer Center, The Valley Hospital, Paramus, NJ, USA
3 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (5) , 1828-1832
Case report and literature review of small bowel obstruction secondary to gastric band tubing
Introduction and Importance: Laparoscopic adjustable gastric banding (LAGB) is a surgical intervention for treating morbid obesity. It is not without its complications and, very rarely, can cause small bowel obstruction (SBO) from the gastric banding tubing interacting with the small bowel. Case Presentation: This case report showcases a rare SBO in a 45-year-old woman who underwent LAGB 5 years prior. Radiological evaluation by CT scan showed dilated proximal bowel loops with air-fluid levels and an abrupt change in caliber in the mid-abdomen, concerning for small bowel obstruction. The patient then underwent a diagnostic laparoscopy, which revealed gastric band tubing looping around the common channel, causing a SBO. The gastric band connection tubing was severed to resolve the obstruction. Clinical Discussion: SBO secondary to LAGB is a very rare complication. Literature review yielded 17 previous cases with various outcomes. Ten required removal of the gastric band tubing, four had the hernia reduced without removal of the tubing or gastric band, and three required bowel resection. When a patient presents with an SBO in the setting of a LAGB, it is important to consider the tubing as a possible cause of an internal hernia. Conclusion: While internal herniations represent a more common complication of Roux-en-Y Gastric Bypass in literature, bariatric surgeons should also consider it after a LAGB procedure.
- 1 April 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (5) , 1828-1832
Open AccessCase report and literature review of small bowel obstruction secondary to gastric band tubing
Introduction and Importance: Laparoscopic adjustable gastric banding (LAGB) is a surgical intervention for treating morbid obesity. It is not without its complications and, very rarely, can cause small bowel obstruction (SBO) from the gastric banding tubing interacting with the small bowel. Case Presentation: This case report showcases a rare SBO in a 45-year-old woman who underwent LAGB 5 years prior. Radiological evaluation by CT scan showed dilated proximal bowel loops with air-fluid levels and an abrupt change in caliber in the mid-abdomen, concerning for small bowel obstruction. The patient then underwent a diagnostic laparoscopy, which revealed gastric band tubing looping around the common channel, causing a SBO. The gastric band connection tubing was severed to resolve the obstruction. Clinical Discussion: SBO secondary to LAGB is a very rare complication. Literature review yielded 17 previous cases with various outcomes. Ten required removal of the gastric band tubing, four had the hernia reduced without removal of the tubing or gastric band, and three required bowel resection. When a patient presents with an SBO in the setting of a LAGB, it is important to consider the tubing as a possible cause of an internal hernia. Conclusion: While internal herniations represent a more common complication of Roux-en-Y Gastric Bypass in literature, bariatric surgeons should also consider it after a LAGB procedure.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Obesity
- Vol. 2026 (1)
Safety and Cost‐Effectiveness of Early Discharge Following Bariatric Surgery in an Underserved Urban Population
This study evaluated the safety and economic impact of discharging bariatric surgery patients on Postoperative day (POD) 1 compared to the institutional POD 2 discharge protocol. A retrospective review of 115 patients who underwent laparoscopic or robot‐assisted sleeve gastrectomy and Roux‐en‐Y gastric bypass (RYGB) revealed no significant differences in complications or readmissions between the groups. Discharge on POD 1 demonstrated a cost difference of approximately $1571. Our findings support the safety, feasibility, and financial benefits of implementing POD 1 discharge as standard practice for bariatric patients in underserved urban populations.
- 1 January 2026
- Published by Wiley in Journal of Obesity
- Vol. 2026 (1)
Open AccessSafety and Cost‐Effectiveness of Early Discharge Following Bariatric Surgery in an Underserved Urban Population
This study evaluated the safety and economic impact of discharging bariatric surgery patients on Postoperative day (POD) 1 compared to the institutional POD 2 discharge protocol. A retrospective review of 115 patients who underwent laparoscopic or robot‐assisted sleeve gastrectomy and Roux‐en‐Y gastric bypass (RYGB) revealed no significant differences in complications or readmissions between the groups. Discharge on POD 1 demonstrated a cost difference of approximately $1571. Our findings support the safety, feasibility, and financial benefits of implementing POD 1 discharge as standard practice for bariatric patients in underserved urban populations.
- 1 October 2020
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 82, 85-86
Invited commentary: Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis
- 1 October 2020
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 82, 85-86
Invited commentary: Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis
- 1 January 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 230 (1) , 136-144
Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features
Thyroid lobectomy (TL) has been proposed as definitive surgical treatment for papillary thyroid cancers (PTC) up to 4 cm. This study evaluates the use and appropriateness of TL for T1b and T2 PTC. The National Cancer Database was interrogated for adult patients having TL for T1b-T2 PTC between 2004 and 2014. Patients who should have undergone total thyroidectomy (TT) instead of lobectomy based on high-risk tumor features were identified. The 2 groups were compared for clinical and demographic characteristics, and overall survival. Of 8,083 patients undergoing lobectomy, 1,552 patients had high-risk features and should have undergone TT. These included 194 with cN1, 571 with pN1, 307 with lymphovascular invasion (LVI), 645 with extra thyroidal extension (ETE), 567 with positive margins, 42 with poorly differentiated PTC, and 25 with M1 disease. At 10 years of follow-up, 92.4% of appropriate lobectomy (aTL) patients were alive compared with 88.5% of inappropriate lobectomy (iTL) patients (p < 0.001). On univariate and multivariable Cox survival analysis, age greater than 45 years, male sex, comorbidities, government or no insurance, low income, and tumor size >2 cm were associated with poorer survival (all p < 0.05). Thyroid lobectomy patients with high-risk features had significantly higher mortality on unadjusted (hazard ratio [HR] 1.98, 95% CI 1.52 to 2.59, p < 0.001) and adjusted survival analysis (HR 1.97, 95% CI 1.51 to 2.58, p < 0.001). Total thyroidectomy with radioiodine treatment had improved overall survival in comparison to iTL (HR 0.65, 95% CI 0.51 to 0.83, p < 0.001). A substantial number of patients (19.2%) with tumor size >1 cm and high-risk features undergo thyroid lobectomy for PTC. Exclusion of high-risk features is important when adopting lobectomy as the definitive surgical therapy for T1b and T2 PTC because they have a potential adverse effect on long-term survival.
- 1 January 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 230 (1) , 136-144
Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features
Thyroid lobectomy (TL) has been proposed as definitive surgical treatment for papillary thyroid cancers (PTC) up to 4 cm. This study evaluates the use and appropriateness of TL for T1b and T2 PTC. The National Cancer Database was interrogated for adult patients having TL for T1b-T2 PTC between 2004 and 2014. Patients who should have undergone total thyroidectomy (TT) instead of lobectomy based on high-risk tumor features were identified. The 2 groups were compared for clinical and demographic characteristics, and overall survival. Of 8,083 patients undergoing lobectomy, 1,552 patients had high-risk features and should have undergone TT. These included 194 with cN1, 571 with pN1, 307 with lymphovascular invasion (LVI), 645 with extra thyroidal extension (ETE), 567 with positive margins, 42 with poorly differentiated PTC, and 25 with M1 disease. At 10 years of follow-up, 92.4% of appropriate lobectomy (aTL) patients were alive compared with 88.5% of inappropriate lobectomy (iTL) patients (p < 0.001). On univariate and multivariable Cox survival analysis, age greater than 45 years, male sex, comorbidities, government or no insurance, low income, and tumor size >2 cm were associated with poorer survival (all p < 0.05). Thyroid lobectomy patients with high-risk features had significantly higher mortality on unadjusted (hazard ratio [HR] 1.98, 95% CI 1.52 to 2.59, p < 0.001) and adjusted survival analysis (HR 1.97, 95% CI 1.51 to 2.58, p < 0.001). Total thyroidectomy with radioiodine treatment had improved overall survival in comparison to iTL (HR 0.65, 95% CI 0.51 to 0.83, p < 0.001). A substantial number of patients (19.2%) with tumor size >1 cm and high-risk features undergo thyroid lobectomy for PTC. Exclusion of high-risk features is important when adopting lobectomy as the definitive surgical therapy for T1b and T2 PTC because they have a potential adverse effect on long-term survival.
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , e72
Preoperative Upper Gastrointestinal Endoscopy vs Esophagogastroduodenoscopy for Detection of Hiatal Hernia in Bariatric Patients: A Retrospective Analysis with Surgical and Financial Implications
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , e72
Preoperative Upper Gastrointestinal Endoscopy vs Esophagogastroduodenoscopy for Detection of Hiatal Hernia in Bariatric Patients: A Retrospective Analysis with Surgical and Financial Implications
- 5 September 2018
- Published by Springer Nature
- p. 123-139
First-Line Therapy for Anaplastic Thyroid Cancer: Operation Versus Medical Management
- 5 September 2018
- Published by Springer Nature
- p. 123-139
First-Line Therapy for Anaplastic Thyroid Cancer: Operation Versus Medical Management
- 1 January 2018
- Published by Elsevier in Endocrine Practice
- Vol. 24 (1) , 27-32
Concordance of Pre-Operative Clinical Stage With Pathologic Stage In Patients ≥45 Years Old With Well-Differentiated Thyroid Cancer
- 1 January 2018
- Published by Elsevier in Endocrine Practice
- Vol. 24 (1) , 27-32
Concordance of Pre-Operative Clinical Stage With Pathologic Stage In Patients ≥45 Years Old With Well-Differentiated Thyroid Cancer
- 1 October 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 214 (4) , 748-751
Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma
- 1 October 2017
- Published by Elsevier in The American Journal of Surgery
- Vol. 214 (4) , 748-751
Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e14
Preoperative Biopsy for >4 cm Papillary Thyroid Carcinoma Increases Compliance with Treatment Guidelines
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , e14
Preoperative Biopsy for >4 cm Papillary Thyroid Carcinoma Increases Compliance with Treatment Guidelines
- 1 July 2016
- Published by Elsevier in Endocrine Practice
- Vol. 22 (7) , 822-831
Timing of Radioactive Iodine Therapy does not Impact Overall Survival in High-Risk Papillary Thyroid Carcinoma
- 1 July 2016
- Published by Elsevier in Endocrine Practice
- Vol. 22 (7) , 822-831
Timing of Radioactive Iodine Therapy does not Impact Overall Survival in High-Risk Papillary Thyroid Carcinoma